A detailed history of Latash Investments, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Latash Investments, LLC holds 243,134 shares of AQST stock, worth $1.11 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares
243,134
Previous 243,134 -0.0%
Holding current value
$1.11 Million
Previous $632,000 91.46%
% of portfolio
1.12%
Previous 0.51%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

BUY
$3.29 - $5.21 $799,910 - $1.27 Million
243,134 New
243,134 $965,000

Others Institutions Holding AQST

About Aquestive Therapeutics, Inc.


  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $243M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track This Portfolio

Track Latash Investments, LLC Portfolio

Follow Latash Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Latash Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Latash Investments, LLC with notifications on news.